Innovative Biomarker Technology Cavidi's Exazym® product offers ultra-sensitive detection of low-abundance biomarkers, providing a significant advantage for biomedical research labs aiming to improve assay sensitivity and accuracy.

Global Market Reach With its products used worldwide by researchers in basic, transitional, and pre-clinical biomarker studies, Cavidi presents opportunities to expand sales into international research institutions and diagnostic labs.

Strategic Expansion Potential As a relatively small company with a focus on innovative solutions, Cavidi is positioned to benefit from collaborations with leading biotech firms or lab equipment developers looking to incorporate ultra-sensitive detection tech.

Growth in HIV Diagnostics Given Cavidi’s background in viral load solutions for HIV, there may be additional opportunities to sell enhanced immunoassay reagents to government health agencies, hospitals, and HIV research organizations.

Market Trends Alignment The increasing demand for early detection biomarkers in personalized medicine and diagnostics creates a strong sales opportunity for Cavidi's advanced detection reagents among biotech and healthcare entities seeking cutting-edge diagnostic tools.